Primary Care/Hospitalist
RSSArticles
-
Association of Coffee Consumption with Total and Cause-specific Mortality
Regular consumption of both caffeinated and decaffeinated coffee were found to be inversely associated with risk of total mortality and mortality attributed to cardiovascular disease and neurologic diseases.
-
High Blood Pressure: How Low Should We Go? SPRINT and a New Meta-analysis
A recent meta-analysis supports the benefit of targeting lower blood pressure levels.
-
ECG Review: What Has Happened in 8 Minutes?
The ECG in the figure illustrates how rapidly ST-T wave changes may develop during active stages of acute ST elevation myocardial infarction. In this case, no more than 8 minutes was necessary for the ECG to evolve from a minimally abnormal tracing to the dramatic picture of diffuse ST-T wave changes.
-
Clinical Briefs
In this section: The measurement of C-reactive protein in hidradenitis patients may enhance assessment of disease severity; studying the relationship between gut flora and mood disorders; and weighing the benefits of administration of pre-exposure prophylaxis immediately before and after sexual activity.
-
Lesinurad Tablets (Zurampic)
Lesinurad is a drug with a different mechanism of action to augment the action of a xanthine oxidase inhibitor, resulting in additional reduction of serum uric acid levels.
-
Why Dentists Are Suddenly Smiling
In this meta-analysis of 51 randomized, controlled studies that included nearly 5000 patients, continuous positive airway pressure and oral appliances resulted in comparable and statistically significant reductions in blood pressure.
-
Diabetes, Dementia, and Hormones
Higher levels of estrogen may exacerbate risks that type 2 diabetes pose for cognitive function decline in older women.
-
Azithromycin remains effective in treatment of urogenital chlamydia, study data suggest
Results of a new study, conducted by researchers at the University of Alabama at Birmingham, the Los Angeles-based University of Southern California, and the Los Angeles County Department of Health Services, confirm that azithromycin remains effective in the treatment of urogenital chlamydia.1
-
Snapshot from National HIV Prevention Conference: Strides have been made, yet hurdles remain
The December 2015 National HIV Prevention Conference saw exciting developments announced by the CDC and partners, including new data on trends and disparities in the U.S. HIV epidemic.
-
New option for vaginal discomfort after menopause
Results of a recent Phase III trial suggest that intravaginal dehydroepiandrosterone could provide women who cannot or do not wish to use intravaginal estrogen with an effective vaginal alternative for easing vaginal symptoms and pain with sex after meno-pause.1 The drug, under development as Intrarosa by Endoceutics, a North American biopharma company, is under review by the FDA.